Upstate is first in region to offer treatment with the recently approved Alzheimer ’s drug, lecanemab

The drug received traditional FDA approval in July 2023 to treat early Alzheimer ’s disease, including mild cognitive impairment or mild dementia due to Alzheimer’s disease.
Source: SUNY Upstate Medical - Category: Universities & Medical Training Tags: News Source Type: news